Local Janssen

Johnson & Johnson Innovative Medicine, formerly known as Janssen, is the pharmaceutical division of the global healthcare giant Johnson & Johnson. The company focuses on six primary therapeutic areas: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. With a robust portfolio of blockbuster drugs such as Stelara, Darzalex, and Tremfya, the company is a leader in developing transformative treatments for complex diseases. Their business model integrates internal R&D with strategic acquisitions and collaborations to maintain a deep pipeline of small molecules and advanced biologics, including cell and gene therapies.